Show simple item record

Authordc.contributor.authorPeña, Pedro 
Authordc.contributor.authorZagolin, Mónica 
Authordc.contributor.authorAcuña, Mónica 
Authordc.contributor.authorNavarrete, Sandra 
Authordc.contributor.authorBustamante, Pilar 
Authordc.contributor.authorCanals Cifuentes, Andrea 
Admission datedc.date.accessioned2019-03-18T11:55:04Z
Available datedc.date.available2019-03-18T11:55:04Z
Publication datedc.date.issued2016
Cita de ítemdc.identifier.citationRevista Medica de Chile, Volumen 144, Issue 8, 2018, Pages 965-971
Identifierdc.identifier.issn07176163
Identifierdc.identifier.issn00349887
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/166925
Abstractdc.description.abstract© 2016, Sociedad Medica de Santiago. All right reserved. Background: Smoking cessation therapies include counseling, psychological management and pharmacological therapy. Varenicline is the most effective and safe medication available. Aim: To study risk factors for the failure of pharmacological smoking cessation therapy with varenicline. Patients and Methods: Retrospective analysis of 281 patients aged 45 ± 11 years (65% males) with a mean consumption of 31 ± 22 packs/year. They completed a smoking cessation program comprising psychological support and use of varenicline in a private clinic. Patients were followed with telephonic interviews during one year. A complete abstinence during one year was considered as a success of the program. Results: The success rate of the program was 53.4%. The factors associated with failure were a high tobacco dependence rate determined with the Fageström test (Odds ratio (OR) 2.47, 95% confidence intervals (CI) 1.16-5.26, p = 0.02). An instruction l
Lenguagedc.language.isoen
Publisherdc.publisherSociedad Medica de Santiago
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
Sourcedc.sourceRevista Medica de Chile
Keywordsdc.subjectTobacco
Keywordsdc.subjectTobacco use cessation
Keywordsdc.subjectTobacco use disorder
Keywordsdc.subjectVarenicline
Títulodc.titleFactors associated with success of a smoking cessation program Factores asociados con el éxito de la terapia antitabaco en pacientes tratados con vareniclina: 10 años de experiencia en un programa multidisciplinario
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadorSCOPUS
Indexationuchile.indexArtículo de publicación SCOPUS
uchile.cosechauchile.cosechaSI


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile